Sign in
Taking people in United StatesNo phase

Comparing two hearing aid sound settings in older adults with Alzheimer's dementia

Tests two hearing aid sound settings in older adults with Alzheimer's dementia and hearing loss.

Key facts

Who runs it
Northwestern University
Where
Chicago and Evanston, United StatesSee the 2 sites
Trial code
Registry title
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
Status
Recruiting
People taking part
20 people, planned
Started
1 Jul 2021
Expected to end
31 Aug 2027
Type of study
Interventional, 2 groups
Treatments tested
  • High level of signal manipulation
  • Low level of signal manipulation
Record updated
30 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older adults aged 50 to 90 with Alzheimer's dementia or amnestic mild cognitive impairment and hearing loss, who do not already wear hearing aids.

Age
50 to 90 years
Sex
All sexes can join.
Disease stage
Alzheimer's dementia or amnestic mild cognitive impairment, with a Clinical Dementia Rating of 0.5 or 1 and a MoCA score of at least 18. Sensorineural hearing loss in both ears, with pure-tone thresholds of 25-70 dB HL between 500 and 3000 Hz.
Earlier treatment
People who wear hearing aids now (at least 4 hours a day on most days in the past year) cannot join.

Main reasons for not taking part

  • Current regular hearing aid wearer
  • Conductive, congenital or fluctuating hearing loss
  • Lasting communication problems after a stroke, brain tumor, neurodevelopmental disorder or head/neck cancer
  • Major psychiatric disorder, such as schizophrenia or significant untreated depression
  • Taking part in another study on hearing, language or communication

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Speak English as their primary language
  • Normal or corrected to normal vision (20/40 binocular vision or unaided using a Snellen chart)
  • Sensorineural hearing loss with pure-tone thresholds 25-70 dB HL at octave frequencies between 500 and 3000 Hz and a 4 frequency (.5, 1, 2, 3 kHz) pure-tone average of greater than or equal to 30 dB in each ear
  • Clinical Dementia Rating (CDR) of 0.5 or 1 (indicating slight or mild cognitive impairment in the areas of memory, orientation, judgment/problem solving, community affairs, behavior at home/hobbies, and personal care)
  • Diagnosis of dementia Alzheimer's type or amnestic mild cognitive impairment (minimum MoCA score of 18)
  • Living at home
  • Minimum Grade 10 education
  • Able to provide own consent as evaluated by the Consent Assessment

Who cannot take part

  • Clinically significant unstable or progressive medical conditions, or conditions which, in the opinion of the investigator(s) places the participant at unacceptable risk if he or she were to participate in the study
  • History of unresolved communication difficulties following another neurological problem (e.g. stroke or brain tumor), neurodevelopmental disorder (e.g. Down's syndrome), or head/neck cancer
  • Positive history of major psychiatric disorder (e.g. schizophrenia, significant untreated depression)
  • Co-enrolled in other intervention studies targeting hearing, language, or communication strategies
  • Conductive hearing loss pathology, congenital hearing loss, or fluctuating hearing loss
  • Current active hearing aid wearer (defined as wearing hearing aid(s) at least 4 hours a day for most days within the past year)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 90 years old?

Where in United States

  • Northwestern UniversityChicago, United StatesContact: Kendra Marks, AuDTaking people
  • Northwestern UniversityEvanston, United StatesContact: Kendra MarksTaking people

About the trial

What the trial wants to find out

This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and its potential precursor, known as amnestic mild cognitive impairment. The investigators hypothesize that adults with Alzheimer's dementia represent an extreme case of restricted cognitive ability, such that very low working memory capacity and overall reduced cognitive capacity will limit benefit from advanced signal processing. Thus, the investigators hypothesize that adults with Alzheimer's dementia will receive greater benefit from acoustically simple, high-fidelity hearing aid processing that minimally alters the acoustic signal.

The 2 groups in the trial

  • Hearing Aid Fitting Order ATreatment being tested

    Participants wear hearing aids with a high level of signal manipulation, followed by a low level of signal manipulation

    Treatment: High level of signal manipulation and Low level of signal manipulation

  • Hearing Aid Fitting Order BTreatment being tested

    Participants wear hearing aids with a low level of signal manipulation, followed by a high level of signal manipulation

    Treatment: High level of signal manipulation and Low level of signal manipulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
Plain-language title
Comparing two hearing aid sound settings in older adults with Alzheimer's dementiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04240561, who can take part
Record updated
30 April 2026